SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-330980
Filing Date
2017-11-02
Accepted
2017-11-02 16:09:45
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d464242d10q.htm 10-Q 637796
2 EX-31.1 d464242dex311.htm EX-31.1 6493
3 EX-31.2 d464242dex312.htm EX-31.2 6068
4 EX-32.1 d464242dex321.htm EX-32.1 4460
11 GRAPHIC g464242g1030181926797.jpg GRAPHIC 20543
  Complete submission text file 0001193125-17-330980.txt   2604832

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT drna-20170930.xml EX-101.INS 399594
6 XBRL TAXONOMY EXTENSION SCHEMA drna-20170930.xsd EX-101.SCH 32765
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20170930_cal.xml EX-101.CAL 45924
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20170930_def.xml EX-101.DEF 83360
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20170930_lab.xml EX-101.LAB 234981
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20170930_pre.xml EX-101.PRE 163216
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 171172404
SIC: 2834 Pharmaceutical Preparations